Jonae Barnes | SVP, IR & Corporate Communications |
Jean-Pierre Sommadossi | CEO and Founder |
John Vavricka | CCO |
Janet Hammond | CDO |
Andrea Corcoran | CFO and Executive President, Legal |
Hannah Adeoye | JPMorgan |
Matthew Harrison | Morgan Stanley |
Umer Raffat | Evercore |
Tim Lugo | William Blair |
Nik Gasic | SVB Securities |
Good afternoon, ladies and gentlemen. Welcome to the Atea Pharmaceuticals' Third Quarter 2022 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode.
Following the formal remarks, we will open the call up for your questions. [Operator Instructions] I will now turn the call over to Jonae Barnes, Senior Vice President of Investor Relations and Corporate Communications at Atea Pharmaceuticals.